Muriel pursued her training (B.A., M.Sc. in Biology and Ph.D. in Biochemistry) at the George Washington University (Washington DC, USA). She undertook postdoctoral training at the National Cancer Institute (Bethesda, MD) on Bovine Papilloma Virus and on neuroblastoma at Pierre and Marie Curie University (Paris, France). She then entered the pharmaceutical and biotechnology sector, first at Lilly France, and then at ExonHit Therapeutic Inc. After obtaining her MBA from Paris Dauphine, Muriel moved to Montréal and joined IRIC in 2006. Since then she has worked as a project manager on Guy Sauvageau‘s team projects. After her family and her work, she spends her time to the pursuit of knowledge about healthy and environmentally friendly lifestyles.